AMPA-NOVA Trademark
Trademark Overview
On Friday, July 11, 2025, a trademark application was filed for AMPA-NOVA with the United States Patent and Trademark Office. The USPTO has given the AMPA-NOVA trademark a serial number of 99278636. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, June 2, 2026. This trademark is owned by Neurocrine Biosciences, Inc.. The AMPA-NOVA trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of anhedonia, major depressive disorder and mood disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of anhedonia, major depressive disorder and mood disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of anhedonia, major depressive disorder and mood disorders, and evaluating epidemiological results for treatments for anhedonia, major depressive disorder and mood disorders; providing ...
Providing medical information; providing medical information relating to therapies and treatments for anhedonia, major depressive disorder and mood disorders
General Information
| Serial Number | 99278636 |
| Word Mark | AMPA-NOVA |
| Filing Date | Friday, July 11, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Tuesday, June 2, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, June 23, 2026 |
Trademark Statements
| Indication of Colors claimed | The color(s) pink and dark navy blue is/are claimed as a feature of the mark. |
| Description of Mark | The mark consists of an open circle from which extend six lines ending in filled circles, all in pink. Below that appears the wording AMPA-NOVA, with AMPA and NOVA appearing in dark navy blue and the hyphen appearing in pink. |
| Goods and Services | Pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of anhedonia, major depressive disorder and mood disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of anhedonia, major depressive disorder and mood disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of anhedonia, major depressive disorder and mood disorders, and evaluating epidemiological results for treatments for anhedonia, major depressive disorder and mood disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials pertaining to therapies and treatments for anhedonia, major depressive disorder and mood disorders |
| Goods and Services | Providing medical information; providing medical information relating to therapies and treatments for anhedonia, major depressive disorder and mood disorders |
| Pseudo Mark | AMPA NOVA |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 11, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 11, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Neurocrine Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130
US |
Trademark Events
| Event Date | Event Description |
| Friday, July 11, 2025 | NEW APPLICATION ENTERED |
| Friday, July 11, 2025 | APPLICATION FILING RECEIPT MAILED |
| Monday, November 17, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, November 17, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, November 25, 2025 | ASSIGNED TO EXAMINER |
| Sunday, November 30, 2025 | NON-FINAL ACTION WRITTEN |
| Sunday, November 30, 2025 | NON-FINAL ACTION E-MAILED |
| Sunday, November 30, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, February 24, 2026 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Tuesday, February 24, 2026 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Tuesday, May 26, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, May 26, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, May 26, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, May 27, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 17, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
